Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations

Parkinsonism and Related Disorders

Volumn 21, Issue 7, 2015, Pages 717-722

  Tijero, Beatriz ^a,b   Gabilondo, Iñigo ^a,b   Lezcano, Elena ^a,b,c   Teran Villagrá, Nuria ^d   Llorens, Verónica ^b   Ruiz Martinez, Javier ^e,f   Marti Masso, Jose Felix ^c,e,f   Carmona, M ^g   Luquin, Maria Rosario ^g   Berganzo, Koldo ^a,b   Fernandez, Ivan ^h   Fernandez, Manuel ^a,b,c   Zarranz, Juan José ^a,b,c   Gómez Esteban, Juan Carlos ^a,b,c  

^a Biocruces Research Institute   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^f HOSPITAL DONOSTIA   (Spain)

^g UNIVERSITY OF NAVARRA   (Spain)

^h HOSPITAL TXAGORRITXU   (Spain)

Author keywords

Autonomic function; Autonomic tests; PARK2 mutation; Parkinson's disease

Indexed keywords

(3 IODOBENZYL)GUANIDINE; ALPHA SYNUCLEIN; NORADRENALIN; VASOPRESSIN; PARKIN; UBIQUITIN PROTEIN LIGASE;

ABNORMAL POSTURE; ADULT; ARTICLE; AUTONOMIC NEUROPATHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE DURATION; FEMALE; GENE; GENE MUTATION; GENETIC ANALYSIS; HEART DENERVATION; HEART SCINTISCANNING; HETEROZYGOTE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MOTOR PERFORMANCE; NORADRENALIN BLOOD LEVEL; ORTHOSTATIC HYPOTENSION; PARK2 GENE; PARKINSONISM; PREVALENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SYMPATHETIC FUNCTION; SYMPATHETIC NERVE; VASOPRESSIN BLOOD LEVEL; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; GENETICS; MIDDLE AGED; MUTATION; PARKINSONIAN DISORDERS;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PARKINSONIAN DISORDERS; UBIQUITIN-PROTEIN LIGASES;

EID: 84930755989     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2015.04.012     Document Type: Article

References (30)

1. Bonifati V. Genetics of Parkinson's disease-state of the art, 2013. Park Relat Disord 2014, 20(Suppl.1):S23-S28.
2. Lohmann E., Periquet M., Bonifati V., Wood N.W., De Michele G., Bonnet A.M., et al. How much phenotypic variation can be attributed to parkin genotype?. Ann Neurol 2003, 54:176-185.
3. Kay D.M., Moran D., Moses L., Poorkaj P., Zabetian C.P., Nutt J., et al. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients. Ann Neurol 2007, 61:47-54.
4. Pramstaller P.P., Schlossmacher M.G., Jacques T.S., Scaravilli F., Eskelson C., Pepivani I., et al. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers. Ann Neurol 2005, 58:411-422.
5. Miyakawa S., Ogino M., Funabe S., Uchino A., Shimo Y., Hattori N., et al. Lewy body pathology in a patient with a homozygous parkin deletion. Mov Disord 2013, 28:388-391.
6. Houlden H., Singleton A.B. The genetics and neuropathology of Parkinson's disease. Acta Neuropathol 2012, 124:325-338.
7. Farrer M., Chan P., Chen R., Tan L., Lincoln S., Hernandez D., et al. Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol 2001, 50:293-300.
8. Khan N.L., Graham E., Critchley P., Schrag A.E., Wood N.W., Lees A.J., et al. Parkin disease: a phenotypic study of a large case series. Brain 2003, 126:1279-1292.
9. Yamamura Y., Hattori N., Matsumine H., Kuzuhara S., Mizuno Y. Autosomal recessive early-onset parkinsonism with diurnal fluctuation: clinicopathologic characteristics and molecular genetic identification. Brain Dev 2000, 22(Suppl.1):S87-S91.
10. Ahlskog J.E. Lessons for Parkinson disease from the parkin genotype. JAMA Neurol 2013, 70:551-552.
11. Doherty K.M., Silveira-Moriyama L., Parkkinen L., Healy D.G., Farrell M., Mencacci N.E., et al. Parkin disease: a clinicopathologic entity?. JAMA Neurol 2013, 70:571-579.
12. Orimo S., Amino T., Yokochi M., Kojo T., Uchihara T., Takahashi A., et al. Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord 2005, 20:1350-1353.
13. Suzuki M., Hattori N., Orimo S., Fukumitsu N., Abo M., Kono Y., et al. Preserved myocardial [123I]metaiodobenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report. Mov Disord 2005, 20:634-636.
14. Hase A., Yamada H., Arai K., Sunada Y., Shimizu T., Matsumura K. Characterization of parkin in bovine peripheral nerve. Brain Res 2002, 930:143-149.
15. Abbruzzese G., Pigullo S., Schenone A., Bellone E., Marchese R., Di Maria E., et al. Does parkin play a role in the peripheral nervous system? A family report. Mov Disord 2004, 19:978-981.
16. Visser M., Marinus J., Stiggelbout A.M., Van Hilten J.J. Assessment of autonomic dysfunction in Parkinson's disease: the SCOPA-AUT. Mov Disord 2004, 19:1306-1312.
17. Ewing D.J., Borsey D.Q., Bellavere F., Clarke B.F. Cardiac autonomic neuropathy in diabetes: comparison of measures of R-R interval variation. Diabetologia 1981, 21:18-24.
18. Tijero B., Gomez-Esteban J.C., Lezcano E., Fernandez-Gonzalez C., Somme J., Llorens V., et al. Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the alpha synuclein gene. Park Relat Disord 2013, 19:95-100.
19. Lucking C.B., Durr A., Bonifati V., Vaughan J., De Michele G., Gasser T., et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. NEngl J Med 2000, 342:1560-1567.
20. Puschmann A. Monogenic Parkinson's disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Park Relat Disord 2013, 19:407-415.
21. Del Sorbo F., Elia A.E., De Joanna G., Romito L.M., Garavaglia B., Albanese A. Normal cardiovascular reflex testing in patients with parkin disease. Mov Disord 2007, 22(4):528-532.
22. Tijero B., Gomez Esteban J.C., Somme J., Llorens V., Lezcano E., Martinez A., et al. Autonomic dysfunction in parkinsonian LRRK2 mutation carriers. Park Relat Disord 2013, 19:906-909.
23. Tijero B., Gomez-Esteban J.C., Llorens V., Lezcano E., Gonzalez-Fernandez M.C., de Pancorbo M.M., et al. Cardiac sympathetic denervation precedes nigrostriatal loss in the E46K mutation of the alpha-synuclein gene (SNCA). Clin Auton Res 2010, 20:267-269.
24. Gouider-Khouja N., Larnaout A., Amouri R., Sfar S., Belal S., Ben Hamida C., et al. Autosomal recessive parkinsonism linked to parkin gene in a Tunisian family. Clinical, genetic and pathological study. Park Relat Disord 2003, 9:247-251.
25. Ahlskog J.E. Parkin and PINK1 parkinsonism may represent nigral mitochondrial cytopathies distinct from Lewy body Parkinson's disease. Park Relat Disord 2009, 15:721-727.
26. Ohsawa Y., Kurokawa K., Sonoo M., Yamada H., Hemmi S., Iwatsuki K., et al. Reduced amplitude of the sural nerve sensory action potential in PARK2 patients. Neurology 2005, 65:459-462.
27. Ceravolo R., Cossu G., Bandettini di Poggio M., Santoro L., Barone P., Zibetti M., et al. Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study. Mov Disord 2013, 28:1391-1397.
28. Kaufmann H., Oribe E., Oliver J.A. Plasma endothelin during upright tilt: relevance for orthostatic hypotension?. Lancet 1991, 338:1542-1545.
29. Cignarelli M., De Pergola G., Paternostro A., Corso M., Cospite M.R., Centaro G.M., et al. Arginine-vasopressin response to supine-erect posture change: an index for evaluation of the integrity of the afferent component of baroregulatory system in diabetic neuropathy. Diabete Metab 1986, 12:28-33.
30. Orimo S., Uchihara T., Kanazawa T., Itoh Y., Wakabayashi K., Kakita A., et al. Unmyelinated axons are more vulnerable to degeneration than myelinated axons of the cardiac nerve in Parkinson's disease. Neuropathol Appl Neurobiol 2011, 37:791-802.